    Bruce Terker | Balyshannon Partners | ZoomInfo.com

Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version
















Bruce E. Terker of Palladiem Llc - Profile



































Home
About

Pricing

Login


























Bruce E. Terker of  PALLADIEM LLC


GO TO FUND PROFILE











About Bruce E. Terker of  PALLADIEM LLC



									
										   Bruce E. Terker is Director at Palladiem Llc and has been affiliated with Palladiem Llc since October-2011. Palladiem Llc is an investment advisor that manages 699 MM dollars in regulatory AUM and has 5 employees, of which 3 perform investment advisory functions. The managers's latest filing has disclosed 64MM in positions, which represents 9% of the manager's regulatory AUM.  For more on Palladiem Llc including top positions, information on the investment process, service provider information, other key employees, real time performance, 13-F holdings and more visit the Fund Profile







 PALLADIEM LLC StockAlpha 





+0.1%





Top 25%



StockAlpha
3 yr performance attributed to stock picking: +0.1%/yr














×
Register to Unlock



Unlock profile and also get:

Manager Positions and Return Details
Position Crowdedness, Turnover & Concentration
Manager Performance Estimates
Top Stock Pickers Report













We take your privacy seriously. Your information will never be shared with any third party












Co-workers of Bruce E. Terker at  PALLADIEM LLC






Name
Title
In Position Since







David M. Feldman
President And Co-Cio
October-2011


Joseph J. Scavetti
Chief Operating Officer
October-2011


David R. Gibson
Chief Financial Officer
October-2011


Steven J. Morgenthal
Director
October-2011


Donald G. Robinson
Ceo And Co-Cio
October-2011


Jason M. Ewasko
Chief Compliance Officer
January-2014










Fundamental & Technical Factor Exposure
										






Market Cap
Beta
Volatility


Momentum (12M)
Momentum (6M)
Momentum (3M)


Price/Book
Price/Earnings
Price/Cash Flow


Dividend Yield
Sales Growth
Earnings Growth


ROE
ROA
ROC


EBIDTA Margin
Debt/Assets
Hedge Fund Crowding













Symmetric Rankings Have Been Featured In






















Bruce E. Terker Office Address



7 GREAT VALLEY PARKWAY								SUITE 295
MALVERN, 
Pennsylvania
UNITED STATES, 
19355








Bruce E. Terker Contact Information



							Phone Number: 888-886-4122
							Fax Number: 877-870-5676
							Website: http://www.palladiem.com









READ RECENT SYMMETRIC REPORTS






















Disclaimer



				
		The information contained herein: (1) is proprietary to Symmetric and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Symmetric nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance and skill metrics are no guarantee of future results. "Symmetric," "Symmetric.io" and the Symmetric logo are marks of Symmetric, Inc. Read our privacy policy here. Read our terms of use here










 











Bruce Evans Terker - Bryn Mawr, PA | Intelius



























Sign In



We found Bruce Evans Terker in Bryn Mawr, PA


Bruce Evans Terker

                                                                           Intelius found that Bruce Evans Terker  is  a male between 60 and 70 years old from Bryn Mawr, PA.  We have connected them to
                6 addresses,
                8 phones,
                and 3 relatives or associates.
         





Also Known As

B E Terker


Get Report Now

Age

Bruce Evans Terker is in his 60s

Bruce Has Lived In

Bryn Mawr, PA
Phoenixville, PA
Chadds Ford, PA

Bruce's Relatives

Cynthia Terker
Jennifer Terker
Ryan Terker







Bruce Evans Terker



Zodiac SignTaurus



GenderMale



Professional Status
President at Ballyshannon Partners LP



Get Report Now










Want to know more about Bruce? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Bruce, or use our people search engine to find others.
Get Background Check on Bruce Evans Terker
Get a Criminal Check on Bruce Evans Terker
Get a Public Record Report on Bruce Evans Terker
Get a People Search Report on Bruce Evans Terker


Bruce Evans Terker's Contact Information
Known Cities Lived In
Find out where Bruce Evans Terker has lived as well as Bruce Evans Terker's phone numbers and email addresses.




Bruce Evans Terker Has Lived in 2 States
Pennsylvania Address for Bruce Evans Terker


325 S B*** M*** A** 

Bryn Mawr, PA


Has Lived In

Bryn Mawr, PA
Phoenixville, PA


Get Full Address Report










Phone Numbers Associated with Bruce Evans Terker

(610) ***-**** - Bryn Mawr, PA 
(610) ***-**** - Bryn Mawr, PA 
(609) ***-**** - Longport, NJ 


Get Full Phone Report



Email Addresses Associated with Bruce Evans Terker

b*****x@***.com
b*****r@***.com
b***e@***.com


Get Email Report




Bruce Evans Terker's Professional Information
Information regarding Bruce Evans Terker's professional history.  Find out previous places Bruce Evans Terker has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Bruce Evans Terker Has Worked at 5 Places
Company: Ballyshannon Partners LP
               Title: President
Company: Ballyshannon Partners LP
               Title: Owner
Bruce Evans Terker's Experience
Title: President
               Company: Ballyshannon Partners LP
Job Details
               Welcome to Ballyshannon Partners.Â This page is under construction.Â  Please see our contact information above and check back soon for our updated website.
Title: Owner
               Company: Ballyshannon Partners LP
Job Details
               Company Size: Less than $1 mil
Additional Professional Information on Bruce Evans Terker

 See Bruce Evans Terker's LinkedIn Profile



Bruce Evans Terker's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Bruce Evans Terker


Bruce Evans Terker's known Social Networks And Potential Email Matches

Find all of Bruce Evans Terker's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Bruce Terker
Username Matches

                  BruceTerker
                  TerkerBruce
                  Bruce.Terker
                  Terker.Bruce
                  Bruce_Terker
                  Terker_Bruce
                  Bruce-Terker
                  Terker-Bruce
                  BTerker
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
B Terker







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.













Bruce E. Terker - Biography

















































































Log in






E-mail



Password







Remember




Forgot password ?









Become a member for free
Sign up





Sign up




New memberSign up for FREE


New customerDiscover our portfolios












 United States
 United Kingdom
 France
 Deutschland
 Schweiz (DE)
 Suisse (FR)










Settings

            Dynamic quotes 


OFFON

















Markets
Equities
North AmericaEuropeAsiaOceaniaMiddle East» More Equities

Indexes
DOW JONESS&P 500NASDAQ 100TSX COMPFTSE 100» More Indexes

Currency / Forex
EUR / USDGBP / USDUSD / JPYUSD / CADAUD / USD» More Currencies

Commodities
GOLDCrude Oil (WTI)Crude Oil (BRENT)SILVERPLATINUM» More Commodities


 News
Latest News
CompaniesMarketsEconomyCurrency / ForexCommoditiesInterest RatesBusiness LeadersFinancial calendarEconomic calendar

Listed company
Analyst reco.RumorsIPOsCapital Markets TransactionsNew ContractsProfits warningsAppointmentsPress ReleasesEventsCorporate actions

Sector News
EnergyBasic MaterialsIndustrialsConsumer CyclicalConsumer Non-CyclicalFinancialsHealthcareTechnologyTelecommunications ServicesUtilities


 Analysis
All AnalysisCommentariesIndex AnalysisStock Trading StrategiesCommodity AnalysisForex Analysis

 Stock Picks
All stock picks

 Portfolios
My Portfolio
Virtual portfolios
4-Traders Portfolios
European PortfolioUSA PortfolioAsian Portfolio


 Screeners
Market Screener HomeFundamental Analyse
Top Investor RatingTop Trading RatingTop ConsensusGrowth stocksYield stocksLow valuations

Technical Analysis
Oversold stocksOverbought stocksClose to resistancesClose to supportsAccumulation phaseMost volatile stocks


 Watchlists
My Watchlists
Watchlists
Top Lists
Yield stocksGrowth stocksUndervalued Stocks


 Top / Flop
Top News
Most Read NewsHot News

Top Fundamentals
Top CapitalizationTop YieldTop PERTop ConsensusTop Fundamentals

Top Technicals
Top RSIUnusual volumesTop GapsTop STIM

Top Movers
Top USATop CanadaTop U.K.Top GermanyTop EuropeTop Asia


 Tools
Market ScreenerDynamic chartFinancial calendarEconomic calendarSector researchCurrency converter

 Our Services
Premium AccessDiscover our Services

 



















 






4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography


Business Leaders




Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors HomeAll newsMost read newsBusiness Leaders Biography


 
















Bruce E. Terker

Public asset : 4,137,076 USDLinked companies : No connection available 





Summary 



Mr. Bruce E. Terker is Independent Director at nFinanSe, Inc., Founder at Ballyshannon Partners LP, and Founder at Odyssey Capital Corp.He is on the Board of Directors at nFinanSe, Inc.Mr. Terker was previously employed as Partner by Geewax, Terker & Co., Inc.



Holdings of Bruce E. Terker 










 NameEquities%Valuation

 Ampio Pharmaceuticals Inc (AMPE) Biotechnology & Medical Research 4,473,3306.56%2,330,605 USD
 Mobivity Holdings Corp (MFON) Software 2,286,2726.28%1,806,155 USD
NFINANSE INC  PFCV SER C300,0007.43%300 USD
NFINANSE INC  PFCV SER D11,3330.26%11 USD
NFINANSE INC  PFCV SER E5,1670.12%5 USD



Most Read News 




07/27 LI KA-SHING : Li Ka-shing's CKI to buy German energy metering firm Ista



07/26DJBERNARD ARNAULT : LVMH's Profit Rises 24% in First Half



07/27 RUPERT MURDOCH : As Murdoch waits, Sky cuts operating costs to protect profits



07/26DJMEG WHITMAN : Meg Whitman Steps Down From HP Board



07/28DJNELSON PELTZ : Procter & Gamble, Peltz Spar on Results -- WSJ



07/28 CARLOS SLIM : Hutchison's Drei buys Tele2 to rival Carlos Slim in Austria



07/26DJDAVID SIMON : Executive Pay Falls for Big Mall Owners as Retail Storm Rages On



07/27DJJEFF BEZOS : Amazon's Jeff Bezos Becomes World's Richest Person



07/28DJELON MUSK : Top Company News of the Day



07/22DJWILBUR ROSS : More Cross-Border Commerce



More news

 


            © 2017 People and Ownership :    









Advertisement








Bruce E. Terker : Connections 


No connection available
 







Popular Business Leaders 


 

William Ackman
Bernard Arnault
Mary Barra
Jeff Bezos
Lloyd Blankfein
Michael Bloomberg
Yannick Bolloré
Warren Buffett
Jean-paul Clozel
Gary Cohn
Michael Dell
Jamie Dimon
Ralph Dommermuth
Sebastian Ebel
John Edwards
David Einhorn
Jeff Fettig
Mark Fields
Carlos Ghosn
Terry Gou
David Henry
Carl Icahn
Li Ka-shing
Michel Landel
Daniel Loeb
Maurice Lévy
Jack Ma
Lakshmi Mittal
Rupert Murdoch
Elon Musk
Peter Nicholas
John Paulson
Nelson Peltz
Georges Plassat
Hasso Plattner
Thomas Rabe
Giuseppe Recchi
Wolfgang Reitzle
Wilbur Ross
Charles Schwab
Igor Sechin
Pascal Soriot
George Soros
Rupert Stadler
Bernard Tapie
John Williamson
Thomas Wilson
Dieter Zetsche
Mark Zuckerberg



A-Z Business Leaders




 



























4-traders.com :MarketsNewsAnalysisStock PicksPortfoliosScreenersWatchlistsTop / FlopToolsOur ServicesAbout :Surperformance SASContact usAdvertiseLegal informationsAbout usStay Connected :FacebookTwitterPartners :Börse: Aktien, Kurse und NachrichtenBest tweets 




   Copyright © 2017 Surperformance. All rights reserved.  












 














Slave













		
		
		  Terker Bruce E Acquired Stake in Ampio Pharmaceuticals, Inc
		
		
		
		
 

 












































Trending
Business
Market
Stock
Privacy Policy






Terker Bruce E Acquired Stake in Ampio Pharmaceuticals, Inc


					

						June 15, 2017 - By Marry Poplack


Investors sentiment increased to 1 in 2016 Q4. Its up 0.09, from 0.91 in 2016Q3. It increased, as 9 investors sold Ampio Pharmaceuticals Inc shares while 16 reduced holdings. 9 funds opened positions while 16 raised stakes. 13.92 million shares or 22.81% more from 11.33 million shares in 2016Q3 were reported.






 Pnc Inc owns 13,659 shares. Tower Research Cap Limited Liability Corp (Trc) holds 0% or 641 shares. 10,200 are held by Lpl Fincl Limited Company. Guggenheim Ltd Co reported 0% in Ampio Pharmaceuticals Inc (NYSEMKT:AMPE). Susquehanna International Llp holds 0% or 2.38M shares in its portfolio. Federated Investors Incorporated Pa holds 0% or 582 shares. Rhumbline Advisers holds 33,976 shares or 0% of its portfolio. Moreover, Manufacturers Life Insur The has 0% invested in Ampio Pharmaceuticals Inc (NYSEMKT:AMPE). Wealthtrust Axiom Ltd Liability owns 10,000 shares for 0% of their portfolio. Schwab Charles Invest Mngmt Incorporated has invested 0% in Ampio Pharmaceuticals Inc (NYSEMKT:AMPE). 18,781 were accumulated by Credit Suisse Ag. Cambridge Inv Rech Advsr holds 0% or 48,724 shares in its portfolio. Blackrock Fund Advsrs owns 0% invested in Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) for 1.61 million shares. Next Grp Incorporated Incorporated holds 0% or 20,000 shares. Plancorp Ltd has 15,000 shares.
The New Terker Bruce E Holding in Ampio Pharmaceuticals, Inc
Terker Bruce E reported SC 13G form with the SEC for Ampio Pharmaceuticals, Inc. Access it here: 000119312517203421. As reported by Terker Bruce E, the filler owns 6.58% or 4,473,330 shares of the Health Care–company.
Ampio Pharmaceuticals, Inc stake is new for [reportingPerson]. Date of activity: June 7, 2017. This shows Terker Bruce E’s positive view for Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc Institutional Sentiment
Filings show 51 investors own Ampio Pharmaceuticals, Inc. The ownership in Q3 2015 is high, at 19.39 % of the outstanding shares. This is increased by 3384057. 13227093 were owned by these investors. 5 funds opened new Ampio Pharmaceuticals, Inc stakes, 11 increased positions. There were 18 that closed positions and 12 reduced them.
 Adam Usdan Trellus Management Company Llc is an investor bullish on Ampio Pharmaceuticals, Inc, owning 116700 shares as of Q3 2015 for 0.49% of its portfolio. Noven Financial Group Inc owns 252667 shares or 0.59% of its portfolio. CO Obermeyer Wood Investment Counsel Lllp have 0.01% of its portfolio for 19508 shares. Further, Knoll Capital Management Lp reported stake worth 4.16% of its portfolio. The OH Camelot Portfolios Llc owns 96000 shares. Ampio Pharmaceuticals, Inc is 0.19% of its portfolio.
Business Profile
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company’s two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema. Ampion is a sub 5000 molecular weight fraction of commercial human serum albumin (HSA). Optina is a low-dose formulation of danazol. The Ampio segment consists of its biopharmaceuticals compounds and the clinical trials associated with them. The Company is primarily developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process, and decreasing vascular permeability.

SEC Form 13G.
The stock increased 2.14% or $0.012 during the last trading session, reaching $0.582. About shares traded. Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) has declined 79.44% since June 15, 2016 and is downtrending. It has underperformed by 96.14% the S&P500.
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The company has market cap of $34.53 million. The Firm is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. It currently has negative earnings. The Company’s two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema.
More notable recent Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) news were published by: Seekingalpha.com which released: “Ampio Pharmaceuticals – Running On Fumes” on February 01, 2017, also Prnewswire.com with their article: “Ampio Pharmaceuticals, Inc. Announces Closing of Registered Direct Offering” published on June 07, 2017, Prnewswire.com published: “Ampio Announces Appointment of Interim Chief Financial Officer” on June 12, 2017. More interesting news about Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) were released by: Reuters.com and their article: “BRIEF-Ampio Pharmaceuticals reports closing of registered direct offering” published on June 07, 2017 as well as Reuters.com‘s news article titled: “BRIEF-Bruce Terker reports 6.58 pct passive stake in Ampio Pharmaceuticals …” with publication date: June 14, 2017.


Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.










 



Free Email Newsletter Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:






  Recent Posts 

$-0.01 EPS Expected for Energy Fuels Inc (USA) (UUUU)


United States Cellular Corp (USM) Analysts See $0.22 EPS


Ur-Energy Inc. (USA) (URG) Analysts See $0.01 EPS


Univar Inc (UNVR) Analysts See $0.31 EPS


$0.35 EPS Expected for TOKYO ELECTRON ADR EACH REPR 0.25 SHS (TOELY)


Analysts See $-0.73 EPS for Tonix Pharmaceuticals Holding Corp. (TNXP)


$0.05 EPS Expected for Telephone & Data Systems, Inc. (TDS)


Territorial Bancorp Inc (TBNK) EPS Estimated At $0.47


Ur-Energy Inc. (URE) EPS Estimated At $0.01


Supremex Inc (SXP) Analysts See $0.15 EPS























            	Get the Next Big Winner in your inbox Before the Bell







            
Lists*Consumer Eagle




Twitter Auto Publish Powered By : XYZScripts.com

















TERKER BRUCE E Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      TERKER BRUCE E
                    

•   BRYN MAWR, PA
                      
How do I update this listing?




                                             Terker Bruce E is based out of Bryn Mawr.    WhaleWisdom has at least 6 13D/G filings in our database for Terker Bruce E.
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from TERKER BRUCE E, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




terker bruce e


325 BRYN MAWR AVENUE

BRYN MAWR
PA
                                                        
                                                    19010









Recent SEC Filings




SC 13G filed on 06/14/2017
SC 13G/A filed on 11/07/2016
SC 13G filed on 09/12/2013
4 filed on 01/04/2011











Current 13D/G Holdings


Stock
Sector
Shares Held
Market Value
Rank
Source
Source Date





Ampio Pharmaceuticals, Inc (AMPE)


      HEALTH CARE
    

      4,473,330
    

      2,728,731.30
    

      1
    

      13G
    

      2017-06-07
    



Mobivity Holdings Corp. (MFON)


      INFORMATION TECHNOLOGY
    

      2,286,272
    

      1,600,390.40
    

      2
    

      13G
    

      2016-10-31
    



nFinaSe Inc (NFSE.OB)


      FINANCE
    

      11,394,446
    

      1,025,500.14
    

      3
    

      13D
    

      2010-03-16
    



Unknown (unknown)




      6,515,657
    



      4
    

      13G
    

      2013-09-12
    











Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free





















Terker Bruce E  - Current Holdings - Fintel.io

































Terker Bruce E 







Current Holdings (from 13F, 13D)


InvestorTerker Bruce E 
Current Positions2


Terker Bruce E  has disclosed 2 total holdings in their latest SEC filings.
        
        
            
                This investor has not filed a 13F, which indicates it has under $100M in Assets Under Management (AUM).
            
        
        
        
        
        
            Terker Bruce E 's top industries are
            
                "Chemicals And Allied Products" (sic 28)
                ,
                 and 
            
                "Business Services" (sic 73)
                
                
            .
        
    

Overview
SEC Filings
13D/13G
Predictive Value









All Terker Bruce E  holdings are listed in the following table.
                This data is sourced from 13D/13G, and 13F filings. Green rows indicate new positions. Red rows indicate closed positions.



Add This Fundto your dashboard



This is a list of 13D and 13G filings made since the last quarterly 13F report (if any).



File DateFormSecurity

PrevShares
CurrentShares
Change(Percent)
Prev Value(x$1000)
Current Value(x$1000)
Change(Percent)




2017‑06‑14
SC 13G
AMPE / Ampio Pharmaceuticals, Inc.

*

4,473,330






2016‑11‑07
SC 13G/A
MFON / Mobivity Holdings Corp.

*

2,286,272
















Fintel IR - Find the Right Investors for Your Company, Instantly!
        Fintel IR combines the comprehensive Fintel ownership database with machine learning to
        provide advanced tools to make investor outreach fast and easy.
        Learn more now!
















Become a power user!

 Join our private investing channel!
Request Membership






























Bruce E. Terker - Former Sole Director at Argosy Private Equity



























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology








            You have  
            
9 free profiles

              left this month   
			      

                Start Your Free Trial ➤
              








            Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there?
            

                View on RelSci Pro ➤
              




























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink





Bruce E. Terker
Former Sole Director at Argosy Private Equity



Overview
Relationships Paths
Career History Boards & Committees Political Donations Public Holdings 


Bruce E. Terker
Former Sole Director at Argosy Private Equity



 Overview



Age



62
                                  (Born 1955)
                                              




Notable Companies


Odyssey Capital Group, Inc.

Ballyshannon Partners LP

Odyssey Capital Corp.




Board Seats



2





Number of Relationships



                This person is connected to 67 people.
              






 Relationships
              See Details




Kirk Griswold

Founding Partner at Argosy Private Equity




John Paul Kirwin III

Co-Founder at Argosy Private Equity





Matt E. Brach

Fund Advisor at Odyssey Capital Group, Inc.




Steven Jay Morgenthal

Director at Palladiem LLC





John Julius Geewax

Chief Investment Officer at Geewax Plus Partners LLC




Richard C. Schwenk, Jr.

Chief Financial Officer & Chief Operating Officer at Argosy Private Equity





Michael Bailey

Partner at Argosy Private Equity




John F. Nugent

Partner at Argosy Private Equity





Keven P. Shanahan

Partner at Argosy Private Equity




Ernest W. Swift

Former Professor at The University of Georgia







See 57 more listings with RelSci Professional.

Start My Free Trial ➤








See 57 More 


 


 Paths to Bruce E. Terker



            Bruce E. Terker          




 You



 Connections via Relationship Science



 Bruce E. Terker






Sync your contacts to see how you can connect with Bruce E. Terker.

Start My Free Trial ➤








See  More 


 


 Career History



Sole Director

                                    2014 - Current                


Argosy Private Equity


                  Argosy Private Equity invests in lower middle market companies located in the US with revenues of $15 - $100 million and EBITDA (cash flow) of $3 - $9 million, margins of 10% or greater. They invest in basic businesses such as manufacturing, assembly, business services, value-added distribution and franchising companies. The firm partners with their investors, co-investors and management teams. They invest in the form of equity and mezzanine for management buyouts, recapitalizations, acquisitions and growth financing transactions with an investment size of $5 - $15 million. They do not invest in retail businesses, start-ups and turnarounds or straight distribution businesses.                




Founder

                                    1993 - Current                


Ballyshannon Partners LP






Founder

                                    1989 - Current                


Odyssey Capital Corp.


                  Part of Power Corp. of Canada, Odyssey Capital Corp. is a company headquartered in St. Catharines, ON, Canada, that manages mutual funds and sells related financial products. It was founded by Bruce E. Terker. On 31 Jan 06 IPC Investment Corp. acquired Odyssey Capital Corp.                




Chairman

                                    1989 - ?                


Odyssey Capital Group, Inc.






Partner

                                    1982 - 2008                


Geewax, Terker & Co., Inc.


                  The investment process used to develop Geewax's portfolios is quantitatively based and model-driven. Stocks are screened on several fundamental criteria in an effort to identify those with the greatest risks of under-performing the benchmark.Portfolio managers are individually responsible for the construction and maintenance of the portfolios.                





 Boards & Committees



Corporate Boards ▾




Director

                    2011 - Current                  


Palladiem LLC

                    Palladiem LLC is an American private company located in Malvern, PA. The firm provides investment advice. It was founded in 2011. Donald George Robinson is currently the CEO of the company.                  




Independent Director

                    2007 - Prior                  


nFinanSe, Inc.

                    nFinanSe, Inc. engages in the provision of stored value cards and reloadable financial products for grocery, convenience, and general merchandise stores. The company was founded on July 10, 2000 and is headquartered in Tampa, FL.                  





 Political Donations



$500

                  2012                


Mitt Romney







$750

                  2010                


Patrick J. Toomey


                  Senator from Pennsylvania                




$500

                  2007                


Joseph A. Sestak, Jr.


                  Former Representative from Pennsylvania's 7th Congressional District                




$250

                  1999                


William Bradley


                  Former Senator from New Jersey                





 Public Holdings






Restricted data only for RelSci Professional users.

Start My Free Trial ➤








See  More 


 


 Other Affiliations




              Bruce E. Terker is affiliated with
                            Argosy Private Equity, Ballyshannon Partners LP, Odyssey Capital Corp., Odyssey Capital Group, Inc., Geewax, Terker & Co., Inc., Palladiem LLC, nFinanSe, Inc..
            





You've reached your 10 free profiles limit this month.
Upgrade to RelSci Pro today to enjoy unlimited article views and much more!

Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.












Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤





















		
		
		  Ampio Pharmaceuticals, Inc: Terker Bruce E Makes Purchase
		
		
		
		
 

 













































Trending
Business
Privacy Policy
Contact






Ampio Pharmaceuticals, Inc: Terker Bruce E Makes Purchase


					

						June 15, 2017 - By Maria Brooks


Investors sentiment increased to 1 in 2016 Q4. Its up 0.09, from 0.91 in 2016Q3. It improved, as 9 investors sold Ampio Pharmaceuticals Inc shares while 16 reduced holdings. 9 funds opened positions while 16 raised stakes. 13.92 million shares or 22.81% more from 11.33 million shares in 2016Q3 were reported.







 New York State Common Retirement Fund invested in 44,900 shares or 0% of the stock. 5,061 are held by Legal General Gp Public Ltd Co. 2,192 are owned by Creative Planning. Northern Corporation invested 0% in Ampio Pharmaceuticals Inc (NYSEMKT:AMPE). Blackrock Inv Mgmt Ltd Limited Liability Company has 163,225 shares for 0% of their portfolio. Manufacturers Life Insur The, Ontario – Canada-based fund reported 1,904 shares. Lpl Fincl Lc has invested 0% in Ampio Pharmaceuticals Inc (NYSEMKT:AMPE). Moreover, Voya Ltd Liability Com has 0% invested in Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) for 22,886 shares. 19,508 are owned by Obermeyer Wood Counsel Lllp. Moreover, Citigroup Inc has 0% invested in Ampio Pharmaceuticals Inc (NYSEMKT:AMPE). Moreover, Cambridge Invest Advsr Inc has 0% invested in Ampio Pharmaceuticals Inc (NYSEMKT:AMPE). Pnc Financial Services has invested 0% in Ampio Pharmaceuticals Inc (NYSEMKT:AMPE). Wealthtrust Axiom Ltd Liability Corporation invested 0% of its portfolio in Ampio Pharmaceuticals Inc (NYSEMKT:AMPE). Concannon Wealth Lc holds 4,000 shares. Amer Group Inc Inc reported 25,263 shares.
The New Terker Bruce E Holding in Ampio Pharmaceuticals, Inc
Terker Bruce E reported SC 13G form with the SEC for Ampio Pharmaceuticals, Inc. Access it here: 000119312517203421. As reported by Terker Bruce E, the filler owns 6.58% or 4,473,330 shares of the Health Care–company.
Ampio Pharmaceuticals, Inc stake is new for [reportingPerson]. Date of activity: June 7, 2017. This shows Terker Bruce E’s positive view for Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc Institutional Sentiment
Filings show 51 investors own Ampio Pharmaceuticals, Inc. The ownership in Q3 2015 is high, at 19.39 % of the outstanding shares. This is increased by 3384057. 13227093 were owned by these investors. 5 funds opened new Ampio Pharmaceuticals, Inc stakes, 11 increased positions. There were 18 that closed positions and 12 reduced them.
 Adam Usdan Trellus Management Company Llc is an investor bullish on Ampio Pharmaceuticals, Inc, owning 116700 shares as of Q3 2015 for 0.49% of its portfolio. Noven Financial Group Inc owns 252667 shares or 0.59% of its portfolio. CO Obermeyer Wood Investment Counsel Lllp have 0.01% of its portfolio for 19508 shares. Further, Knoll Capital Management Lp reported stake worth 4.16% of its portfolio. The OH Camelot Portfolios Llc owns 96000 shares. Ampio Pharmaceuticals, Inc is 0.19% of its portfolio.
Business Profile
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company’s two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema. Ampion is a sub 5000 molecular weight fraction of commercial human serum albumin (HSA). Optina is a low-dose formulation of danazol. The Ampio segment consists of its biopharmaceuticals compounds and the clinical trials associated with them. The Company is primarily developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process, and decreasing vascular permeability.

SEC Form 13G.
The stock increased 2.14% or $0.012 during the last trading session, reaching $0.582. About shares traded. Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) has declined 79.44% since June 15, 2016 and is downtrending. It has underperformed by 96.14% the S&P500.
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The company has market cap of $34.53 million. The Firm is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. It currently has negative earnings. The Company’s two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema.
More notable recent Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) news were published by: Prnewswire.com which released: “Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering” on June 02, 2017, also Reuters.com with their article: “BRIEF-Bruce Terker reports 6.58 pct passive stake in Ampio Pharmaceuticals …” published on June 14, 2017, Prnewswire.com published: “Ampio Announces Appointment of Interim Chief Financial Officer” on June 12, 2017. More interesting news about Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) were released by: Prnewswire.com and their article: “Ampio Pharmaceuticals, Inc. Announces Closing of Registered Direct Offering” published on June 07, 2017 as well as Reuters.com‘s news article titled: “BRIEF-Ampio Pharmaceuticals reports closing of registered direct offering” with publication date: June 07, 2017.


Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.











 





Free Email Newsletter Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:






  Recent Posts 

Energy Fuels Inc (USA) (UUUU) Analysts See $-0.01 EPS


United States Cellular Corp (USM) Analysts See $0.22 EPS


Ur-Energy Inc. (USA) (URG) EPS Estimated At $0.01


$0.31 EPS Expected for Univar Inc (UNVR)


TOKYO ELECTRON ADR EACH REPR 0.25 SHS (TOELY) EPS Estimated At $0.35


Analysts See $-0.73 EPS for Tonix Pharmaceuticals Holding Corp. (TNXP)


Analysts See $0.05 EPS for Telephone & Data Systems, Inc. (TDS)


Territorial Bancorp Inc (TBNK) EPS Estimated At $0.47


Analysts See $0.01 EPS for Ur-Energy Inc. (URE)


$0.15 EPS Expected for Supremex Inc (SXP)























            	Get the Next Big Winner in your inbox Before the Bell







            
Lists*Consumer Eagle




Twitter Auto Publish Powered By : XYZScripts.com

















